Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice

Cell Biology and Toxicology

Volumn 17, Issue 6, 2001, Pages 357-370

  Khynriam, D ^a   Prasad, S B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Blood; Buthionine sulfoximine; Cisplatin; Cysteine; Dalton lymphoma; Erythrocytes; Glutathione; Leukocytes

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; CYSTEINE; GLUTATHIONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; BLOOD LEVEL; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE COUNT; ERYTHROCYTE STRUCTURE; ERYTHROCYTE VOLUME; HEMOGLOBIN DETERMINATION; LEUKOCYTE COUNT; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CISPLATIN; CYSTEINE; DRUG THERAPY, COMBINATION; ERYTHROCYTE COUNT; ERYTHROCYTES; GLUTATHIONE; HEMATOCRIT; HEMOGLOBINS; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOMA; MICE; MICE, INBRED STRAINS;

ANIMALIA;

EID: 0035653026     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013784115683     Document Type: Article

References (53)

1. Effect of cisplatin on testicular tissue and the Leydig cell-pituitary axis
2. Nutritional and metabolic aspects of glutathione
3. Improved method for the determination of blood glutathione
4. The anticancer drug cisplatin increases the naturally occurring cell-mediated lysis of tumor cells
5. Basic haematological techniques
6. SH groups and glutathione in cancer patients' blood
7. Chemotherapeutic agents and erythron
8. Reduced erythrocyte defence mechanisms against free radical toxicity in patients with chronic renal failure
9. Regulation of glutathione metabolism in Ehrlich ascites tumour cells
10. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays
11. Vitamin C mediated protection on cisplatin-induced mutagenicity in mice
12. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin
13. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine
14. Neurotoxic side effects of cisplatin
15. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
16. Hematological complications of cancer chemotherapy
17. Glutathione-associated cisdiamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells
18. The role of cisplatin in chemotherapy of advanced breast cancer
19. Embryotoxicity of cisplatin in rats and mice
20. Effect of cisplatin on mitochondrial protein, glutathione and succinate dehydrogenase in Dalton lymphoma-bearing mice
21. Nephrotoxicity of cis-dichlorodiammineplatinum
22. Glutathione metabolism and its selective modification
23. Glutathione-ascorbic acid antioxidant system in animals
24. Blood and plasma glutathione measured in healthy subjects by HPLC: Relation to sex, aging, biological variables and life habits
25. Effect of buthionine sulfoximine on Pt II and Pt IV drug accumulation and the formation of glutathione conjugates in human ovariancarcinoma cell lines
26. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus
27. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo
28. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats
29. Modulation of cisplatin toxicity in blood platelets by glutathione depletion
30. Tumor inhibition and haematopoitic stimulation in mice by a synthetic copper-ATP complex
31. Interactions between mammalian cell DNA and inorganic platinum compounds
32. ATP-driven efflux of glutathione-conjugates, antitumor drugs and xenobiotics from human erythrocytes
33. Binding of the antitumor drug cisdiamminedichloroplatinum(II) (cisplatin) to DNA
34. Antitumour effect of cisplatin against murine ascites Dalton's lymphoma
35. Potentiation by Lbuthionine sulfoximine (BSO) of cytotoxicity of platinum(IV) complexes in sensitive and resistant human ovarian carcinoma cells
36. Studies on the chromosomes of murine Dalton's lymphoma cells and the effect of cisplatin on chromosomes of these cells and bone marrow cells in vivo
37. Effect of cis-dichlorodiammineplatinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin
38. Cisplatin-induced changes in tissue calcium and potassium concentrations in tumour-bearing mice
39. Cisplatin- mediated enzymatic changes in mice bearing ascites Dalton's lymphoma
40. Anemia in cancer
41. Fundamental studies with cisplatin
42. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients
43. Systemic deficiency of glutathione in cystic fibrosis
44. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent
45. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiscent fibroblasts
46. Quinone induced oxidative stress elevates glutathione and induces gamma-glutamyl cysteine synthetase activity in rat lung epithelial L2 cells
47. Glutathione deficiency and human immunodeficiency virus infection
48. Production of large amounts of hydrogen peroxide by human tumor cells
49. Depletion of tumor glutathione in vivo by buthionine sulfoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth
50. Cellular glutathione turnover in vitro with emphasis on type II pneumocytes
51. Endogenous glutathione conjugates: Occurrence and biological functions
52. Cisplatin and DNA repair in cancer chemotherapy